JP2021528096A5 - - Google Patents

Info

Publication number
JP2021528096A5
JP2021528096A5 JP2020573481A JP2020573481A JP2021528096A5 JP 2021528096 A5 JP2021528096 A5 JP 2021528096A5 JP 2020573481 A JP2020573481 A JP 2020573481A JP 2020573481 A JP2020573481 A JP 2020573481A JP 2021528096 A5 JP2021528096 A5 JP 2021528096A5
Authority
JP
Japan
Prior art keywords
cells
exosome
lipid
modified rna
pharmaceutical composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020573481A
Other languages
English (en)
Japanese (ja)
Other versions
JP7897689B2 (ja
JP2021528096A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2019/067232 external-priority patent/WO2020002540A1/en
Publication of JP2021528096A publication Critical patent/JP2021528096A/ja
Publication of JP2021528096A5 publication Critical patent/JP2021528096A5/ja
Priority to JP2024034020A priority Critical patent/JP2024081661A/ja
Application granted granted Critical
Publication of JP7897689B2 publication Critical patent/JP7897689B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020573481A 2018-06-28 2019-06-27 エキソソーム細胞外小胞及びその使用方法 Active JP7897689B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024034020A JP2024081661A (ja) 2018-06-28 2024-03-06 エキソソーム細胞外小胞及びその使用方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862691348P 2018-06-28 2018-06-28
US62/691,348 2018-06-28
PCT/EP2019/067232 WO2020002540A1 (en) 2018-06-28 2019-06-27 Exosome extracellular vesicles and methods of use

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024034020A Division JP2024081661A (ja) 2018-06-28 2024-03-06 エキソソーム細胞外小胞及びその使用方法

Publications (3)

Publication Number Publication Date
JP2021528096A JP2021528096A (ja) 2021-10-21
JP2021528096A5 true JP2021528096A5 (cg-RX-API-DMAC7.html) 2022-07-04
JP7897689B2 JP7897689B2 (ja) 2026-07-30

Family

ID=67139730

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2020573481A Active JP7897689B2 (ja) 2018-06-28 2019-06-27 エキソソーム細胞外小胞及びその使用方法
JP2024034020A Withdrawn JP2024081661A (ja) 2018-06-28 2024-03-06 エキソソーム細胞外小胞及びその使用方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024034020A Withdrawn JP2024081661A (ja) 2018-06-28 2024-03-06 エキソソーム細胞外小胞及びその使用方法

Country Status (5)

Country Link
US (1) US12109310B2 (cg-RX-API-DMAC7.html)
EP (1) EP3813798A1 (cg-RX-API-DMAC7.html)
JP (2) JP7897689B2 (cg-RX-API-DMAC7.html)
CN (1) CN112543629A (cg-RX-API-DMAC7.html)
WO (1) WO2020002540A1 (cg-RX-API-DMAC7.html)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MA49421A (fr) 2017-06-15 2020-04-22 Modernatx Inc Formulations d'arn
MX2020002348A (es) 2017-08-31 2020-10-08 Modernatx Inc Métodos de elaboración de nanopartículas lipídicas.
US12090235B2 (en) 2018-09-20 2024-09-17 Modernatx, Inc. Preparation of lipid nanoparticles and methods of administration thereof
CN113939282A (zh) 2019-01-31 2022-01-14 摩登纳特斯有限公司 制备脂质纳米颗粒的方法
TW202220637A (zh) * 2020-08-06 2022-06-01 美商現代公司 製備脂質奈米顆粒之方法
JP7633787B2 (ja) * 2020-09-23 2025-02-20 三洋化成工業株式会社 細胞外小胞の製造方法
MX2023004371A (es) 2020-10-14 2023-07-26 George Mason Res Foundation Inc Lípidos ionizables, y métodos de fabricación y uso de los mismos.
EP4387657A4 (en) * 2021-08-17 2025-05-21 Monash University Lipid nanoparticle formulations
WO2023178500A1 (en) * 2022-03-22 2023-09-28 Beijing Theraxyte Bioscience Co. Ltd. Therapeutic vesicles and methods of processing the same
CN114848608B (zh) * 2022-05-17 2024-01-30 东南大学 一种蛋白或多肽递送载体及其制备方法与应用
CN115887758B (zh) * 2022-11-15 2024-01-26 西南交通大学 负载外泌体促进糖尿病创面修复的共聚水凝胶
CN117679354B (zh) * 2024-02-04 2024-05-28 知想(山东)医疗科技有限公司 金花茶外泌体制剂及其制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT2419144T (pt) 2009-04-17 2019-09-16 Univ Oxford Innovation Ltd Composição para a administração de material genético
JP2010285426A (ja) 2009-05-11 2010-12-24 National Cancer Center 核酸導入方法
KR20220038506A (ko) 2009-06-10 2022-03-28 알닐람 파마슈티칼스 인코포레이티드 향상된 지질 조성물
CN103068980B (zh) 2010-08-02 2017-04-05 瑟纳治疗公司 使用短干扰核酸(siNA)的RNA干扰介导的联蛋白(钙粘蛋白关联蛋白质),β1(CTNNB1)基因表达的抑制
US8691750B2 (en) 2011-05-17 2014-04-08 Axolabs Gmbh Lipids and compositions for intracellular delivery of biologically active compounds
ES2923757T3 (es) 2011-12-16 2022-09-30 Modernatx Inc Composiciones de ARNm modificado
EA037503B1 (ru) * 2014-01-21 2021-04-05 Анджариум Байосайенсиз Аг Способ получения гибридосомы, гибридосома, полученная при помощи способа, и способ доставки терапевтического или диагностического средства
CA2953341C (en) 2014-06-25 2023-01-24 Acuitas Therapeutics Inc. Lipids and lipid nanoparticle formulations for delivery of nucleic acids
EP3247328B1 (en) * 2015-01-21 2026-01-07 Genevant Sciences Gmbh Methods, compositions, and systems for delivering therapeutic and diagnostic agents into cells
EP3500244B1 (en) * 2016-08-22 2026-07-08 Lonza Sales AG Methods of suppressing delivery of exosomes to liver and spleen
EP3292861A1 (en) 2016-09-13 2018-03-14 Centre National De La Recherche Scientifique (Cnrs) An in vitro method for obtaining a biohybrid vector

Similar Documents

Publication Publication Date Title
JP7635131B2 (ja) 脂質ナノ粒子の調製方法
Min et al. BDNF-enriched small extracellular vesicles protect against noise-induced hearing loss in mice
TWI825602B (zh) 用於細胞內遞送治療劑之化合物及組合物
CN108368028B (zh) 用于递送核酸的新型脂质和脂质纳米颗粒制剂
CN114269360A (zh) 用于治疗递送的平台、组合物和方法
Zeng et al. Micro Trojan horses: Engineering extracellular vesicles crossing biological barriers for drug delivery
CN118647601A (zh) 用于脂质纳米颗粒的氟代阳离子脂质
JP2020532528A (ja) 脂質ナノ粒子の生成方法
US20240148794A1 (en) Lnp compositions comprising payloads for in vivo therapy
CN116693411A (zh) 用于递送核酸的新型羰基脂质和脂质纳米颗粒制剂
TW201534578A (zh) 新穎脂質
EP3107549B1 (en) Anionic polyplexes for use in the delivery of nucleic acids
Liu et al. Distinct molecular properties and functions of small EV subpopulations isolated from human umbilical cord MSCs using tangential flow filtration combined with size exclusion chromatography
Shao et al. Extracellular vesicles participate in macrophage-involved immune responses under liver diseases
CN119654141A (zh) 脂质纳米颗粒的组合物
WO2023036148A1 (zh) 一类阳离子脂质化合物及其应用
EP4424670A1 (en) Lipid compound and lipid nanoparticle composition
EP3675871A1 (en) Compositions and methods for the treatment of fibrotic diseases
EP4529928A2 (en) Compositions, methods and uses of messenger rna
JP2025533111A (ja) Rnaコンストラクト及びその使用
CN110898231B (zh) 一种功能化拉洛他赛脂质体及其制备方法与应用
CN119330848A (zh) 用于递送的脂质化合物及脂质纳米颗粒
KR20200136430A (ko) 점액 층을 가로지르는 마이크로/나노입자의 전위를 향상시키기 위한 알지네이트 올리고머의 용도
TW201726614A (zh) 作為陽離子性脂質之化合物
CN111154755B (zh) 一种双链寡核苷酸dna及其应用